Researchers report a step forward in understanding the pathology of Alzheimer's disease. Two genes that are commonly mutated in the early-onset form of Alzheimer's may cause the disorder by altering how presynaptic neurons release neurotransmitters, according to a study published this week in Nature.
The mechanism may apply to other neurodegenerative disorders as well, the researchers say. "This is a new concept that's interesting to know," said molecular neurobiologist linkurl:Ilya Bezprozvanny;http://www4.utsouthwestern.edu/ilya/ of the Southwestern Medical Center at Dallas, who was not involved in the work. More than 100 different mutations in two genes coding for the proteins presenilin 1 and 2 are associated with early-onset Alzheimer's disease, but the exact effects of these mutations on neural function is still unclear. "It's the first [study] suggesting that presenilins play a presynaptic role," Bezprozvanny said. In 2007, molecular geneticist and neuroscientist linkurl:Jie Shen;http://www.hms.harvard.edu/dms/neuroscience/fac/shen.html of Harvard Medical School and...
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?